JAC Antimicrob Resist. 2026 Apr 7;8(2):dlag033. doi: 10.1093/jacamr/dlag033. eCollection 2026 Apr. ABSTRACT BACKGROUND: Unverified drug allergies pose a significant barrier to successful antimicrobial stewardship efforts.
J Allergy Clin Immunol Pract. 2025 Nov 28:S2213-2198(25)01135-3. doi: 10.1016/j.jaip.2025.11.030. Online ahead of print. ABSTRACT Unverified penicillin allergy labels are common and can result in
World Allergy Organ J. 2025 Aug 12;18(8):101086. doi: 10.1016/j.waojou.2025.101086. eCollection 2025 Aug. ABSTRACT Hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) have been classified as immediate
Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01569-2. doi: 10.1016/j.anai.2024.10.010. Online ahead of print. NO ABSTRACT PMID:39383942 | DOI:10.1016/j.anai.2024.10.010
J Allergy Clin Immunol. 2024 Oct 2:S0091-6749(24)01023-6. doi: 10.1016/j.jaci.2024.09.021. Online ahead of print. NO ABSTRACT PMID:39366523 | DOI:10.1016/j.jaci.2024.09.021
J Allergy Clin Immunol Pract. 2024 May;12(5):1095-1106. doi: 10.1016/j.jaip.2024.03.021. ABSTRACT Risk stratification in drug allergy implies that specific risk categories (eg, low, moderate, and high)
J Allergy Clin Immunol. 2023 Nov 29:S0091-6749(23)01516-6. doi: 10.1016/j.jaci.2023.11.025. Online ahead of print. ABSTRACT BACKGROUND: Current guidelines recommend a stepwise approach to postpartum pain management,
J Allergy Clin Immunol Pract. 2023 Mar 20:S2213-2198(23)00301-X. doi: 10.1016/j.jaip.2023.03.017. Online ahead of print. ABSTRACT BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are indicated for post-operative pain
J Allergy Clin Immunol. 2023 Feb 3:S0091-6749(23)00144-6. doi: 10.1016/j.jaci.2023.01.020. Online ahead of print. ABSTRACT BACKGROUND: Multiple monoclonal antibodies are currently approved for the treatment of
J Allergy Clin Immunol Pract. 2022 Dec 22:S2213-2198(22)01314-9. doi: 10.1016/j.jaip.2022.12.006. Online ahead of print. NO ABSTRACT PMID:36566780 | DOI:10.1016/j.jaip.2022.12.006